Molecular and Cellular Biochemistry (2020) 476:1-10
10.1007/s11010-020-03814-7
The authors have retracted this article because, after publication, it was brought to their attention that some images overlap with those in other articles. In particular:
Figure 7B (panel 400X vs. Ad-shNC) overlaps with Fig. 7D (panel Ki67 vs. Ad-shNC) of [1]
Figure 7B (panel 100X vs. Ad-snNC) overlap with Fig. 2F MCF-7 (panel 100X vs. NC) of [2]
The authors have stated that the immunohistochemistry experiments were performed by a third party; this was not reported in the article. All authors agree to this retraction.
Footnotes
The online version of the original article can be found at 10.1007/s11010-020-03814-7.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Zhou K, Mai H, Zheng S, Cai W, Yang X, Chen Z, Zhan B. OTUB1-mediated deubiquitination of FOXM1 up-regulates ECT-2 to promote tumor progression in renal cell carcinoma. Cell & bioscience. 2020;10(1):1–2. doi: 10.1186/s13578-020-00408-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dong L, Chen F, Fan Y, Long J. MiR-34b-5p inhibits cell proliferation, migration and invasion through targeting ARHGAP1 in breast cancer. Am J Translational Res. 2020;12(1):269. [PMC free article] [PubMed] [Google Scholar]